MYCOSIS FUNGOIDES
Clinical trials for MYCOSIS FUNGOIDES explained in plain language.
Never miss a new study
Get alerted when new MYCOSIS FUNGOIDES trials appear
Sign up with your email to follow new studies for MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tested for rare skin cancer
Disease control TerminatedThis small, early-stage study is testing whether combining a special light treatment (phototherapy) with the drug mogamulizumab works better for people with early-stage mycosis fungoides, a type of skin lymphoma. The goal is to see if this combination can better control the disea…
Matched conditions: MYCOSIS FUNGOIDES
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New combo therapy tested for Tough-to-Treat skin cancer
Disease control OngoingThis study is testing whether combining two existing drugs, pembrolizumab and gemcitabine, can help control advanced forms of a rare skin cancer called mycosis fungoides or Sézary syndrome. It is for adults whose disease has worsened after at least one prior treatment. The main g…
Matched conditions: MYCOSIS FUNGOIDES
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Targeted therapy tested for Hard-to-Treat skin cancers
Disease control OngoingThis study tested whether the drug brentuximab vedotin could help control three types of CD30-positive skin lymphomas in patients whose disease had come back or did not respond to prior treatments. The drug is designed to find and enter cancer cells with a specific marker (CD30) …
Matched conditions: MYCOSIS FUNGOIDES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Supercharged immune cells take aim at tough lymphomas in groundbreaking trial
Disease control OngoingThis study is testing a new type of personalized cell therapy for adults whose CD30+ lymphomas have come back or not responded to standard treatments. Doctors take a patient's own immune cells (T cells), genetically modify them to better find and attack cancer cells, and then inf…
Matched conditions: MYCOSIS FUNGOIDES
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug tested for Tough-to-Treat skin cancer
Disease control OngoingThis early-stage study is testing a new drug called tulmimetostat (DZR123) in patients with advanced mycosis fungoides or Sézary syndrome, which are types of skin lymphoma. The main goal is to check if the drug is safe and to find the right dose for future studies. Researchers wi…
Matched conditions: MYCOSIS FUNGOIDES
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC